GPR119 as a fat sensor

Trends in Pharmacological Sciences

Volumn 33, Issue 7, 2012, Pages 374-381

  Hansen, Harald S ^a   Rosenkilde, Mette M ^a   Holst, Jens J ^a   Schwartz, Thue W ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

2 MONOACYLGLYCEROL; 2 OLEOYLGLYCEROL; 5 HYDROXYEICOSAPENTAENOIC ACID; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; APD 597; APD 668; AR 231453; CHOLECYSTOKININ; DOPAMINE DERIVATIVE; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 119; G PROTEIN COUPLED RECEPTOR 120; GLUCAGON LIKE PEPTIDE 1; GLYCEROL DERIVATIVE; GSK 1292263; HORMONE SENSITIVE LIPASE; ICOSAPENTAENOIC ACID; INSULIN; LYSOPHOSPHOLIPID; MBX 2982; N OLEOYLDOPAMINE; N OLEOYLETHANOLAMINE; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

DRUG STRUCTURE; DRUG TARGETING; FAT INTAKE; FOOD DEPRIVATION; GLUCOSE METABOLISM; HORMONE RELEASE; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; INTESTINE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS; PANCREAS ISLET; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANIMALS; DIABETES MELLITUS, TYPE 2; DRUG DESIGN; HUMANS; HYPOGLYCEMIC AGENTS; MICE; MICE, TRANSGENIC; MOLECULAR TARGETED THERAPY; OLEIC ACIDS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84862654709     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2012.03.014     Document Type: Review

References (68)

1. Ahren, B. (2009) Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Nat. Rev. Drug Discov. 8, 369-385
2. Lauffer, L. et al. (2008) GPR119: 'double-dipping' for better glycemic control. Endocrinology 149, 2035-2037
3. Semple, G. et al. (2008) Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119. J. Med. Chem. 51, 5172-5175
4. Holst, J.J. et al. (2011) Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetes. Diabetes Care 34 (Suppl. 2), S251-S257
5. Chu, Z.L. et al. (2007) A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release. Endocrinology 148, 2601-2609
6. Chu, Z.L. et al. (2008) A role for intestinal endocrine cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucagon-like peptide-1 and glucose-dependent insulinotropic peptide release. Endocrinology 149, 2038-2047
7. Reimann, F. et al. (2008) Glucose sensing in L cells: a primary cell study. Cell Metab. 8, 532-539
8. Parker, H.E. et al. (2009) Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells. Diabetologia 52, 289-298
9. Mortensen, K. et al. (2003) GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine. Regul. Pept. 114, 189-196
10. Theodorakis, M.J. et al. (2006) Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP. Am. J. Physiol. Endocrinol. Metab. 290, E550-E559
11. Soga, T. et al. (2005) Lysophosphatidylcholine enhances glucosedependent insulin secretion via an orphan G-protein-coupled receptor. Biochem. Biophys. Res. Commu. 326, 744-751
12. Sakamoto, Y. et al. (2006) Expression and distribution of Gpr119 in the pancreatic islets of mice and rats: predominant localization in pancreatic polypeptide-secreting PP-cells. Biochem. Biophys. Res. Commun. 351, 474-480
13. Chu, Z.L. et al. (2010) N-Oleoyldopamine enhances glucose homeostasis through the activation of GPR119. Mol. Endocrinol. 24, 161-170
14. Lan, H. et al. (2012) GPR119 agonists mediate GLP-1 secretion from mouse enteroendocrine cells through glucose-independent pathways. Br. J. Pharmacol. 165, 2799-2807
15. Lan, H. et al. (2009) GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis. J. Endocrinol. 201, 1058-1066
16. Fredriksson, R. et al. (2003) Seven evolutionarily conserved human rhodopsin G protein-coupled receptors lacking close relatives. FEBS Lett. 554, 381-388
17. Overton, H.A. et al. (2006) Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab. 3, 167-175
18. Parker, H.E. et al. (2010) Molecular mechanisms underlying nutrient-stimulated incretin secretion. Expert Rev. Mol. Med. 12, e1
19. Gutierrez-Aguilar, R. and Woods, S.C. (2011) Nutrition and L and K-enteroendocrine cells. Curr. Opin. Endocrinol. Diabetes Obes. 18, 35-41
20. Cho, E. et al. (2006) Dietary choline and betaine assessed by food-frequency questionnaire in relation to plasma total homocysteine concentration in the Framingham Offspring Study. Am. J. Clin. Nutr. 83, 905-911
21. Persson, E.M. et al. (2006) A clinical single-pass perfusion investigation of the dynamic in vivo secretory response to a dietary meal in human proximal small intestine. Pharm. Res. 23, 742-751
22. Quehenberger, O. et al. (2010) Lipidomics reveals a remarkable diversity of lipids in human plasma. J. Lipid Res. 51, 3299-3305
23. Hansen, K.B. et al. (2011) 2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans. J. Clin. Endocrinol. Metab. 96, E1409-E1417
24. Kogure, R. et al. (2011) 5-Hydroxy-eicosapentaenoic acid is an endogenous GPR119 agonist and enhances glucose-dependent insulin secretion. Biochem. Biophys. Res. Commun. 416, 58-63
25. Lauffer, L.M. et al. (2009) GPR119 is essential for oleoylethanolamide- induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell. Diabetes 58, 1058-1066
26. Ning, Y. et al. (2008) Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells. Br. J. Pharmacol. 155, 1056-1065
27. Luberto, C. and Hannun, Y.A. (2000) Use of short-chain ceramides. Methods Enzymol. 312, 407-420
28. Verkade, H.J. et al. (2007) The phosphatidylethanolamine N-methyltransferase pathway is quantitatively not essential for biliary phosphatidylcholine secretion. J. Lipid Res. 48, 2058-2064
29. Thomas, C. et al. (2009) TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab. 10, 167-177
30. Nielsen, M.J. et al. (2004) Food intake is inhibited by oral oleoylethanolamide. J. Lipid Res. 45, 1027-1029
31. Rodriguez de Fonseca, F. et al. (2001) An anorexic lipid mediator regulated by feeding. Nature 414, 209-212
32. Fu, J. et al. (2008) Targeted enhancement of oleoylethanolamide production in proximal small intestine induces across-meal satiety in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295, R45-R50
33. Maccarrone, M. et al. (2010) The endocannabinoid system and its relevance for nutrition. Annu. Rev. Nutr. 30, 423-440
34. Gaetani, S. et al. (2010) The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin. J. Neurosci. 30, 8096-8101
35. Fu, J. et al. (2005) Oleoylethanolamide, an endogenous PPAR-α agonist, lowers body weight and hyperlipidemia in obese rats. Neuropharmacology 48, 1147-1153
36. Diep, T.A. et al. (2011) Dietary fat decreases intestinal levels of the anorectic lipids through a fat sensor. FASEB J. 25, 765-774
37. Carr, R.D. et al. (2008) Incretin and islet hormonal responses to fat and protein ingestion in healthy men. Am. J. Physiol. Endocrinol. Metab. 295, E779-E784
38. Artmann, A. et al. (2008) Influence of dietary fatty acids on endocannbinoid and n-acylethanolamine levels in rat brain, liver and small intestine. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1781, 200-212
39. Schwartz, G.J. et al. (2008) The lipid messenger OEA links dietary fat intake to satiety. Cell Metab. 8, 281-288
40. Fu, J. et al. (2007) Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine. J. Biol. Chem. 282, 1518-1528
41. Garrido-López, A. et al. (2006) Determination of oleamide and erucamide in polyethylene films by pressureised fluid extraction and gas chromatography. J. Chromatogr. A 1124, 51-56
42. McDonald, G.R. et al. (2008) Bioactive contaminants leach from disposable laboratory plasticware. Science 322, 917
43. Skonberg, C. et al. (2010) Pitfalls in the sample preparation and analysis of N-acylethanolamines. J. Lipid Res. 51, 3062-3073
44. Driscoll, W.J. et al. (2007) Oleamide synthesizing activity from rat kidney: identification as cytochrome c. J. Biol. Chem. 282, 22353-22363
45. Merkler, D.J. et al. (1996) Fatty acid amide biosynthesis: a possible new role for peptidylglycine a-amidating enzyme and acyl-coenzyme A:glycine N-acyltransferase. Arch. Biochem. Biophys. 330, 430-434
46. Chu, C.J. et al. (2003) N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia. J. Biol. Chem. 278, 13633-13639
47. Tan, B. et al. (2006) Targeted lipidomics: discovery of new fatty acyl amides. AAPS J. 8, E461-E465
48. McCue, J.M. et al. (2009) In vitro synthesis of arachidonoyl amino acids by cytochrome c. Prostaglandins Other Lipid Mediat. 90, 42-48
49. Hansen, H.S. and Artmann, A. (2008) Endocannabinoids and nutrition. J. Neuroendocrinol. 201 (Suppl. 1), 94-99
50. Riserus, U. et al. (2009) Dietary fats and prevention of type 2 diabetes. Prog. Lipid Res. 48, 44-51
51. Liou, A.P. et al. (2011) The G-protein-coupled receptor GPR40 directly mediates long-chain fatty acid-induced secretion of cholecystokinin. Gastroenterology 140, 903-912
52. Beglinger, S. et al. (2010) Role of fat hydrolysis in regulating glucagonlike Peptide-1 secretion. J. Clin. Endocrinol. Metab. 95, 879-886
53. Hirasawa, A. et al. (2005) Free fatty acids regulate gut incretin glucagonlike peptide-1 secretion through GPR120. Nat. Med. 11, 90-94
54. Oh, D.Y. et al. (2010) GPR120 Is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142, 687-698
55. Iakoubov, R. et al. (2011) Essential role for protein kinase Cz in oleic acid-induced glucagon-like peptide-1 secretion in vivo in the rat. Endocrinology 152, 1244-1252
56. Mu, H.L. and Hoy, C.E. (2004) The digestion of dietary triacylglycerols. Prog. Lipid Res. 43, 105-133
57. Yao, L. et al. (2002) Separation of micelles and vesicles within lumenal aspirates from healthy humans: solubilization of cholesterol after a meal. J. Lipid Res. 43, 654-660
58. Thomsen, C. et al. (1999) Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects. Am. J. Clin. Nutr. 69, 1135-1143
59. Sanders, T.A. et al. (2011) Palmitic acid in the sn-2 position of triacylglycerols acutely influences postprandial lipid metabolism. Am. J. Clin. Nutr. 94, 1433-1441
60. Yen, C.L. et al. (2009) Deficiency of the intestinal enzyme acyl CoA:monoacylglycerol acyltransferase-2 protects mice from metabolic disorders induced by high-fat feeding. Nat. Med. 15, 442-446
61. Okawa, M. et al. (2009) Role of MGAT2 and DGAT1 in the release of gut peptides after triglyceride ingestion. Biochem. Biophys. Res. Commun. 390, 377-381
62. Hata, T. et al. (2011) JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses food intake and gastric emptying with the elevation of plasma peptide YY and glucagon-like peptide-1 in a dietary fat-dependent manner. J. Pharmacol. Exp. Ther. 336, 850-856
63. Cantley, J. and Biden, T.J. (2010) Targeting triglyceride/fatty acid cycling in beta-cells as a therapy for augmenting glucose-stimulated insulin secretion. Islets 2, 127-129
64. Fex, M. et al. (2009) A beta cell-specific knockout of hormone-sensitive lipase in mice results in hyperglycaemia and disruption of exocytosis. Diabetologia 52, 271-280
65. Peyot, M.L. et al. (2009) Adipose triglyceride lipase is implicated in fuel and non-fuel stimulated insulin secretion. J. Biol. Chem. 284, 16848-16859
66. Lyubachevskaya, G. and Boyle-Roden, E. (2000) Kinetics of 2- monoacylglycerol acyl migration in model chylomicra. Lipids 35, 1353-1358
67. Shah, U. and Kowalski, T.J. (2010) GPR119 agonists for the potential treatment of type 2 diabetes and related metabolic disorders. Vitam. Horm. 84, 415-448
68. Jones, R.M. and Leonard, J.N. (2009) The emergence of GPR119 agonists as anti-diabetic agents. Ann. Rep. Med. Chem. 44, 149-170